One of the most promising -- and pressing -- areas of research has to do with the effects of medical marijuana on people with diabetes.
The legalization of recreational marijuana has dominated the news, recently, but medical marijuana research continues to advance apace.
Earlier this year, the FDA approved the first prescription drug derived from cannabis to treat epilepsy.
This approval marks a watershed moment for legitimizing the active ingredients of medical marijuana as a viable treatment for diseases, even though marijuana advocates have been promoting myriad treatment possibilities for decades.
Click here to read the complete article
Andre Bourque ~ Forbes.com ~
